A reply to Short-term effect of intravitreal anti-VEGFs delivery on intraocular pressure.
Amissah-Arthur
Kwesi N
KN
Rashid
Alia
A
Quhill
Fahd
F
D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D006801:Humans; D007462:Iodobenzenes / Q000627:therapeutic use*; D008268:Macular Degeneration / Q000188:drug therapy; D009798:Ocular Hypertension / Q000517:prevention & control*; D011446:Prospective Studies; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
D020533:Angiogenesis Inhibitors; D000959:Antihypertensive Agents; D007462:Iodobenzenes; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; C041028:iodipine